Charles Schwab

Charles Schwab Portfolio holdings

AUM $578B
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Quarter Return
+2.45%
1 Year Return
+20.71%
3 Year Return
+82.52%
5 Year Return
+159.25%
10 Year Return
+378.54%
AUM
$542B
AUM Growth
+$542B
Cap. Flow
+$31.1B
Cap. Flow %
5.73%
Top 10 Hldgs %
22.88%
Holding
3,563
New
62
Increased
2,302
Reduced
836
Closed
70
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
STI icon
3401
Solidion Technology
STI
$8.83M
$97.4K ﹤0.01%
139,753
+79,277
+131% +$55.2K
OPAD icon
3402
Offerpad Solutions
OPAD
$158M
$96.4K ﹤0.01%
33,838
WNEB icon
3403
Western New England Bancorp
WNEB
$257M
$95.2K ﹤0.01%
10,349
DTI icon
3404
Drilling Tools International
DTI
$71.3M
$92.5K ﹤0.01%
28,283
ATNM icon
3405
Actinium Pharmaceuticals
ATNM
$55.5M
$90.8K ﹤0.01%
72,093
CAMP icon
3406
CAMP4 Therapeutics Corporation Common Stock
CAMP
$30.6M
$87.1K ﹤0.01%
+16,685
New +$87.1K
LPTH icon
3407
Lightpath Technologies
LPTH
$230M
$85.3K ﹤0.01%
24,173
GALT icon
3408
Galectin Therapeutics
GALT
$274M
$83.9K ﹤0.01%
65,073
BW icon
3409
Babcock & Wilcox
BW
$225M
$83.9K ﹤0.01%
+51,145
New +$83.9K
ZVIA icon
3410
Zevia
ZVIA
$210M
$83.8K ﹤0.01%
20,011
IVVD icon
3411
Invivyd
IVVD
$204M
$82.7K ﹤0.01%
186,680
-24,069
-11% -$10.7K
ACRS icon
3412
Aclaris Therapeutics
ACRS
$209M
$82K ﹤0.01%
+33,079
New +$82K
JBIO
3413
Jade Biosciences, Inc. Common Stock
JBIO
$258M
$77.8K ﹤0.01%
29,351
ORGN icon
3414
Origin Materials
ORGN
$80.2M
$76.8K ﹤0.01%
60,000
SBDS
3415
Solo Brands, Inc.
SBDS
$20.1M
$76.3K ﹤0.01%
66,898
LDI icon
3416
loanDepot
LDI
$448M
$75.4K ﹤0.01%
36,984
RSSS icon
3417
Research Solutions
RSSS
$98.3M
$75K ﹤0.01%
18,069
PHX
3418
DELISTED
PHX Minerals
PHX
$74.3K ﹤0.01%
18,580
UHG icon
3419
United Homes Group
UHG
$245M
$73.6K ﹤0.01%
17,396
DMAC icon
3420
DiaMedica Therapeutics
DMAC
$295M
$72K ﹤0.01%
13,251
PFIE
3421
DELISTED
Profire Energy, Inc
PFIE
$70.3K ﹤0.01%
27,669
ELEV
3422
DELISTED
Elevation Oncology
ELEV
$69.9K ﹤0.01%
124,181
VTGN icon
3423
VistaGen Therapeutics
VTGN
$102M
$68.7K ﹤0.01%
23,302
OTLK icon
3424
Outlook Therapeutics
OTLK
$37.8M
$68.1K ﹤0.01%
36,048
-15,411
-30% -$29.1K
BCOV
3425
DELISTED
Brightcove, Inc.
BCOV
$67.6K ﹤0.01%
15,530